Discover 524 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Calgary runs one of the busiest research programs in western Canada, with hundreds of studies recruiting at any given time.The Arthur J.E. Child Comprehensive Cancer Centre opened in Calgary in October 2024, making cancer research the city's fastest-growing trial area. Roughly a third of Calgary's recruiting studies are in oncology, and the rest cluster around heart failure, kidney disease, and metabolic conditions, much of it run through the University of Calgary. The city is also unusual for the volume of paediatric research at Alberta Children's Hospital, so families often find studies here that are not available elsewhere in the province.
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
for
Myeloma, Myeloma Multiple
Location: Calgary, Edmonton
Sponsor: AHS Cancer Control Alberta
Sex: All
Age: 18+
Code: NCT04268199
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
for
DCIS
Location: Calgary, Edmonton, Saskatoon,
Sponsor: Ontario Clinical Oncology Group (OCOG)
Sex: Female
Age: 46+
Code: NCT04797299
Recruiting
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Location: Calgary, Los Angeles CA, Iowa City IA, Warrenville IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 12+
Code: NCT04924075
Phase2, Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Calgary, Edmonton, Fort Collins CO, Loveland CO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06057402
Recruiting
SNV1521 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Calgary, West Valley City UT, Toronto, Nashville TN,
Sponsor: Synnovation Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06220864
Phase1, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Calgary, Omaha NE, Rochester MN, Duarte CA, Phoenix AZ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06121843
Phase1, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Calgary, Vancouver, Salt Lake City UT, Los Angeles CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase3, Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
